Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein (Proceedings of the National Academy of Sciences of the United States of America (2009) 106, 31, (13010-13015) DOI: 10.1073/pnas.0903691106);Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 31, 2009, Pages 13010-13015

  Desplats, Paula ^a   Lee, He Jin ^b,c   Bae, Eun Jin ^b   Patrick, Christina ^a   Rockenstein, Edward ^a   Crews, Leslie ^a   Spencer, Brian ^a   Masliah, Eliezer ^a   Lee, Seung Jae ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Konkuk University   (South Korea)

^c Konkuk University School of Medicine   (South Korea)

Author keywords

Lewy body; Neurodegeneration; Parkinson's disease; Protein aggregation

Indexed keywords

ALPHA SYNUCLEIN; CASPASE 3;

APOPTOSIS; ARTICLE; BRAIN NERVE CELL; CELL DEATH; DEGENERATIVE DISEASE; DISEASE COURSE; ENDOCYTOSIS; FRAGMENTATION REACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEWY BODY; LYSOSOME; NERVE CONDUCTION; PARKINSON DISEASE; PATHOLOGY; PRIORITY JOURNAL; PROTEIN QUALITY; STEM CELL; TRANSGENIC ANIMAL; ANIMAL; C57BL MOUSE; CELL LINE; METABOLISM; MOUSE; NERVE CELL; PHYSIOLOGY; RAT; STEM CELL TRANSPLANTATION; SYNAPTIC TRANSMISSION; TRANSGENIC MOUSE; TRANSPORT AT THE CELLULAR LEVEL;

ALPHA-SYNUCLEIN; ANIMALS; APOPTOSIS; BIOLOGICAL TRANSPORT; CELL LINE; HUMANS; LEWY BODIES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEURONS; RATS; STEM CELL TRANSPLANTATION; SYNAPTIC TRANSMISSION;

EID: 69149089854     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0909220106     Document Type: Erratum

References (33)

1. Kim C, Lee S-J (2008) Controlling the mass action of α-synuclein in Parkinson's disease. J Neurochem 107:303-316.
2. Lesage S, Brice A (2009) Parkinson's disease: From monogenic forms to genetic susceptibility factors. Hum Mol Genet 18:R48-R59.
3. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M (1998) α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 95:6469-6473.
4. Maries E, Dass B, Collier TJ, Kordower JH, Steece-Collier K (2003) The role of α-synuclein in Parkinson's disease: Insights from animal models. Nat Rev Neurosci 4:727-738.
5. Cookson MR (2005) The biochemistry of Parkinson's disease. Annu Rev Biochem 74:29-52.
6. Dauer W, Przedborski S (2003) Parkinson's disease: Mechanisms and models. Neuron 39:889-909.
7. Forno LS (1996) Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol 55:259-272.
8. Braak H, et al. (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24:197-211.
9. Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW (2008) Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat Med 14:504-506.
10. Li JY, et al. (2008) Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med 14:501-503.
11. Brundin P, Li JY, Holton JL, Lindvall O, Revesz T (2008) Research in motion: The enigma of Parkinson's disease pathology spread. Nat Rev Neurosci 9:741-745.
12. Lee S-J (2008) Origins and effects of extracellular α-synuclein: Implications in Parkinson's disease. J Mol Neurosci 34:17-22.
13. Lee H-J, Patel S, Lee S-J (2005) Intravesicular localization and exocytosis of α-synuclein and its aggregates. J Neurosci 25:6016-6024.
14. Lee H-J, et al. (2008) Assembly-dependent endocytosis and clearance of extracellular α-synuclein. Int J Biochem Cell Biol 40:1835-1849.
15. Lee H-J, Suk JE, Bae EJ, Lee S-J (2008) Clearance and deposition of extracellular α-synuclein aggregates in microglia. Biochem Biophys Res Commun 372:423-428.
16. Rockenstein E, et al. (2002) Differential neuropathological alterations in transgenic mice expressing α-synuclein from the platelet-derived growth factor and Thy-1 promoters. J Neurosci Res 68:568-578.
17. Pan T, Kondo S, Le W, Jankovic J (2008) The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease. Brain 131:1969-1978.
18. Dawson TM, Dawson VL (2003) Molecular pathways of neurodegeneration in Parkinson's disease. Science 302:819-822.
19. Caughey B (2000) Transmissible spongiform encephalopathies, amyloidoses and yeast prions: Common threads? Nat Med 6:751-754.
20. Meyer-Luehmann M, et al. (2006) Exogenous induction of cerebral β-amyloidogenesis is governed by agent and host. Science 313:1781-1784.
21. Ren PH, et al. (2009) Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates. Nat Cell Biol 11:219-225.
22. Frost B, Jacks RL, Diamond MI (2009) Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem 284:12845-12852.
23. Bahr BA, Bendiske J (2002) The neuropathogenic contributions of lysosomal dysfunction. J Neurochem 83:481-489.
24. Futerman AH, van Meer G (2004) The cell biology of lysosomal storage disorders. Nat Rev Mol Cell Biol 5:554-565.
25. Suzuki K, et al. (2003) Neuronal accumulation of α- and β-synucleins in the brain of a GM2 gangliosidosis mouse model. NeuroReport 14:551-554.
26. Suzuki K, et al. (2007) Neuronal and glial accumulation of α- and β-synucleins in human lipidoses. Acta Neuropathol 114:481-489.
27. Gitler AD, et al. (2009) α-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nat Genet 41:308-315.
28. Ramirez A, et al. (2006) Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet 38:1184-1191.
29. Mendez I, et al. (2008) Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years. Nat Med 14:507-509.
30. Kordower JH, Chu Y, Hauser RA, Olanow CW, Freeman TB (2008) Transplanted dopaminergic neurons develop PD pathologic changes: A second case report. Mov Disord 23:2303-2306.
31. Lee H-J, Khoshaghideh F, Patel S, Lee S-J (2004) Clearance of α-synuclein oligomeric intermediates via the lysosomal degradation pathway. J Neurosci 24:1888-1896.
32. Lee H-J, Shin SY, Choi C, Lee YH, Lee S-J (2002) Formation and removal of α-synuclein aggregates in cells exposed to mitochondrial inhibitors. J Biol Chem 277:5411-5417.
33. Lee H-J, et al. (2009) Neuron-to-glia transmission of α-synuclein causes glial inclusion formation and immune responses in synucleinopathies. J Exp Med, in press.